95 related articles for article (PubMed ID: 8874137)
1. U50,488H-induced pressor effect in the ovine foetus is mediated by sympathetic activation and vasopressin.
Szeto HH; Wu D; Yee JS; Soong Y; Fukuda S; Taylor CT
Eur J Pharmacol; 1996 Aug; 309(2):183-7. PubMed ID: 8874137
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and respiratory actions of U50,488H in the unanaesthetized ovine foetus.
Szeto HH; Wu D; Cheng PY; Soong Y; Taylor CC; Yee J
Eur J Pharmacol; 1996 Feb; 297(1-2):77-82. PubMed ID: 8851169
[TBL] [Abstract][Full Text] [Related]
3. kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor.
Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH
J Pharmacol Exp Ther; 1996 May; 277(2):877-84. PubMed ID: 8627570
[TBL] [Abstract][Full Text] [Related]
4. Baroreflex-mediated bradycardia is blunted by intravenous mu- but not kappa-opioid agonists.
Omoniyi AT; Wu D; Soong Y; Szeto HH
J Cardiovasc Pharmacol; 1998 Jun; 31(6):954-9. PubMed ID: 9641482
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective and antiarrhythmic effect of U50,488H in ischemia/reperfusion rat heart.
Cheng L; Ma S; Wei LX; Guo HT; Huang LY; Bi H; Fan R; Li J; Liu YL; Wang YM; Sun X; Zhang QY; Yu SQ; Yi DH; Ma XL; Pei JM
Heart Vessels; 2007 Sep; 22(5):335-44. PubMed ID: 17879026
[TBL] [Abstract][Full Text] [Related]
6. The kappa-opioid receptor agonist, U50,488H, exerts antidystonic activity in a mutant hamster model of generalized dystonia.
Richter A; Löscher W
Eur J Pharmacol; 1993 May; 236(2):289-94. PubMed ID: 8391460
[TBL] [Abstract][Full Text] [Related]
7. [Delayed electrical uncoupling is involved in kappa-opioid receptor activation -induced cardioprotective effect in the isolated rat heart].
Chen BP; Fan FY; Mao HJ; Xia Q
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2006 Feb; 22(1):64-70. PubMed ID: 21186583
[TBL] [Abstract][Full Text] [Related]
8. The Protective Effects of Κ-Opioid Receptor Stimulation in Hypoxic Pulmonary Hypertension Involve Inhibition of Autophagy Through the AMPK-MTOR Pathway.
Zhou Y; Wang Y; Wang X; Tian X; Zhang S; Yang F; Guo H; Fan R; Feng N; Jia M; Gu X; Wang Y; Li J; Pei J
Cell Physiol Biochem; 2017; 44(5):1965-1979. PubMed ID: 29224002
[TBL] [Abstract][Full Text] [Related]
9. In vivo modulation of post-spike excitability in vasopressin cells by kappa-opioid receptor activation.
Brown CH; Leng G
J Neuroendocrinol; 2000 Aug; 12(8):711-4. PubMed ID: 10929081
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic U50,488H treatment on binding and mechanical responses of the rat hearts.
Xia Q; Sheng JZ; Tai KK; Wong TM
J Pharmacol Exp Ther; 1994 Feb; 268(2):930-4. PubMed ID: 8114007
[TBL] [Abstract][Full Text] [Related]
11. Role of κ-opioid receptor in hypoxic pulmonary artery hypertension and its underlying mechanism.
Zhang L; Li J; Shi Q; Fan R; Kaye AJ; Wang Y; Sun X; Rivera FB; Kaye AD; Pei J
Am J Ther; 2013; 20(4):329-36. PubMed ID: 23838631
[TBL] [Abstract][Full Text] [Related]
12. Agonist-induced desensitization and down-regulation of the human kappa opioid receptor expressed in Chinese hamster ovary cells.
Zhu J; Luo LY; Mao GF; Ashby B; Liu-Chen LY
J Pharmacol Exp Ther; 1998 Apr; 285(1):28-36. PubMed ID: 9535991
[TBL] [Abstract][Full Text] [Related]
13. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis.
Yin W; Zhang P; Huang JH; Zhang QY; Fan R; Li J; Zhou JJ; Hu YZ; Guo HT; Zhang SM; Wang YM; Kaye AD; Gu CH; Liu JC; Cheng L; Cui Q; Yi DH; Pei JM
Eur J Pharmacol; 2009 Apr; 607(1-3):135-42. PubMed ID: 19233160
[TBL] [Abstract][Full Text] [Related]
15. U50,488H depresses pulmonary pressure in rats subjected to chronic hypoxia.
Pei JM; Sun X; Guo HT; Ma S; Zang YM; Lu SY; Bi H; Wang YM; Ma H; Ma XL
J Cardiovasc Pharmacol; 2006 Apr; 47(4):594-8. PubMed ID: 16680074
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of [3H]-U69593 binding and the cardiac effects of U50, 488H by calcium channel blockers in the rat heart.
Zhang WM; Wang HX; Xia Q; Wong TM
Br J Pharmacol; 1997 Mar; 120(5):827-32. PubMed ID: 9138688
[TBL] [Abstract][Full Text] [Related]
17. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.
Yu XC; Wang HX; Pei JM; Wong TM
J Mol Cell Cardiol; 1999 Oct; 31(10):1809-19. PubMed ID: 10525419
[TBL] [Abstract][Full Text] [Related]
18. Kappa agonists inhibit gastric emptying but not acid secretion in rhesus monkeys.
Touzeau PL; Shea-Donohue T
J Pharmacol Exp Ther; 1990 Jun; 253(3):1010-6. PubMed ID: 1972746
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms involved in the hypotensive effect of a kappa-opioid receptor agonist in hypertensive rats.
Guo HT; Zhang RH; Huang LY; Li J; Liu YL; Bi H; Zhang QY; Wang YM; Sun X; Ma XL; Cheng L; Liu JC; Yu SQ; Yi DH; Pei JM
Arch Med Res; 2007 Oct; 38(7):723-9. PubMed ID: 17845890
[TBL] [Abstract][Full Text] [Related]
20. Vasorelaxing effect of U50,488H in pulmonary artery and underlying mechanism in rats.
Sun X; Ma S; Zang YM; Lu SY; Guo HT; Bi H; Wang YM; Ma H; Ma XL; Pei JM
Life Sci; 2006 Apr; 78(21):2516-22. PubMed ID: 16336977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
